Obesema 1.7mg Injection

Obesema 1.7mg Injection – Semaglutide for Weight Management

Obesema 1.7mg Injection contains Semaglutide 1.7mg, a GLP-1 receptor agonist used as part of a comprehensive weight management program for adults with obesity or excess body weight associated with weight-related health conditions. It helps regulate appetite, reduce food intake, and support sustainable weight loss when combined with a healthy diet and regular physical activity. Semaglutide works by mimicking the action of a natural hormone called GLP-1, which helps control hunger and food cravings. It acts on areas of the brain involved in appetite regulation, helping individuals feel fuller for longer and consume fewer calories throughout the day. Obesema 1.7mg Injection is administered once weekly and should be used under the supervision of a qualified healthcare professional as part of an individualized weight management plan.

Key Features

• Supports Weight Loss: Helps reduce appetite and calorie intake.
• Contains Semaglutide 1.7mg: A GLP-1 receptor agonist used for chronic weight management.
• Once-Weekly Administration: Convenient dosing schedule.
• Helps Control Hunger: Promotes a feeling of fullness after meals.
• Works with Diet & Exercise: Designed to complement lifestyle modifications.

Key Ingredient

• Semaglutide 1.7mg: Helps regulate appetite and support long-term weight management.

How to Use

• Use exactly as prescribed by your healthcare professional.
• Administer as a subcutaneous injection once weekly.
• Inject into the abdomen, thigh, or upper arm as directed.
• Use on the same day each week, at any time of day.
• Follow the recommended diet and exercise program during treatment.

Precautions

• Use only under medical supervision.
• Inform your doctor about any history of pancreatitis, thyroid disorders, kidney disease, or gastrointestinal conditions.
• Do not share injection devices with others.
• Store as directed on the product packaging.
• Keep out of reach of children.

Warning

• May cause nausea, vomiting, diarrhea, constipation, abdominal pain, or decreased appetite.
• Seek immediate medical attention if severe abdominal pain or allergic reactions occur.
• Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
• Do not exceed the prescribed dosage.

Legal Disclaimer: Obesema 1.7mg Injection is a prescription medication intended for chronic weight management in eligible adults. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.